DcMAF terápia
Externally administered GcMAF rebuilds the immune system, enabling it to eliminate early-stage cancer and other diseases.
How does GcMAF work?
In a healthy person your GcMAF acts as a "director" of your immune system. But viruses and malignant cells like cancer send out an enzyme called Nagalase that prevents production of your GcMAF: that neutralises your immune system. So diseases become chronic, and cancer cells grow unchecked.
In three weeks of one GcMAF dose a week, your immune system is rebuilt to above normal strength. You need one dose a week for typically 24 weeks for many diseases and early cancers, a year for later stage cancers.
Research result
- The GcMAF Conference 2013 revealed that GcMAF is a significantly more potent molecule than previously understood, demonstrating impressive scientific findings and positive outcomes reported by physicians.
- In cases of stage 4 cancer, certain doctors utilizing appropriate complementary therapies, as outlined in our "Treatment Strategies," have achieved complete recovery for all their patients.
- We have observed remarkable success with various common cancers, including prostate, lung, and breast cancer, as well as some positive outcomes with leukemia and melanoma.
- GcMAF has proven effective in addressing chronic inflammation, bacterial and viral infections, and has shown promise in treating conditions such as Autism, Chronic Herpes, Chronic Acne, CFS, Lyme disease, Fibromyalgia, Osteoporosis, and various immune dysfunctions, including allergies.
- Research indicates that GcMAF may reverse conditions like HIV and Parkinson’s disease, prevent progression in MS and ALS, and can also combat immune system disorders such as Lupus and Arthritis, with severe liver cirrhosis requiring over 15 months for treatment.